LIBERTY MACIAS: Open Payments
NPI 1376936476 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136,441 in 376 payments from 17 companies in 2025. Trend: 2023 $52,537 · 2024 $39,440 · 2025 $136,441
Speaker / faculty: $87,855Travel & lodging: $18,159Honoraria: $11,540Food & beverage: $9,854Consulting: $8,810Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 68 | $34,892 |
| E.R. Squibb & Sons, L.L.C. | 55 | $32,808 |
| ABBVIE INC. | 101 | $24,250 |
| Alkermes, Inc. | 29 | $17,356 |
| Axsome Therapeutics, Inc. | 35 | $15,726 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $4,987 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 9 | $4,589 |
| Otsuka America Pharmaceutical, Inc. | 25 | $566 |
| Janssen Pharmaceuticals, Inc | 8 | $289 |
| Neurocrine BioSciences, Inc. | 13 | $256 |
Products named: COBENFY, UZEDY, VRAYLAR, LYBALVI, Auvelity, AUSTEDO XR, CAPLYTA, REJOYN.
Industry payments across CA — which companies pay providers there.
